Helen Lima Del Puerto

Prof. Dr. Helen Lima Del Puerto

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2018 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
CACamila P. Almeida
Camila P. Almeida
MFMárcia C. F. Ferreira
Márcia C. F. Ferreira
CSCamila O. Silveira
Camila O. Silveira
JCJacira R. Campos
Jacira R. Campos
IBIsabella T. Borges
Isabella T. Borges
HPHelen Lima Del Puerto
Helen Lima Del Puerto

1 January 2010 in Journal Of Hypertension
Verified
Journal Article
Closed access
AMAmy Milsted
Amy Milsted
AUAdam Underwood
Adam Underwood
JDJeff Dunmire
Jeff Dunmire
HPHelen Lima Del Puerto
Helen Lima Del Puerto
AMALMIR DE SOUSA MARTINS
ALMIR DE SOUSA MARTINS
MTMonte E Turner
Monte E Turner
Background and objective We demonstrated that the Sry gene complex on the spontaneously hypertensive rat (SHR) Y chromosome is a candidate locus for hypertension that accounts for the SHR Y chromosome blood pressure effect. All rat strains examined to date share six Sry loci, and a seventh Sry locus (Sry3) appears to be unique to SHR male rats. Previously, we showed that Sry1 increased activity of the tyrosine hydroxylase promoter in transfected PC12 cells, and Sry1 delivered to adrenal gland of Wistar–Kyoto (WKY) rats increased blood pressure and sympathetic nervous system activity. The objective of this study was to determine whether renin–angiotensin system genes participate in Sry-mediated effects. Method Sry expression vectors were co-transfected into CHO cells with luciferase reporter constructs containing promoters of angiotensinogen (Agt −1430/+22), renin (Ren −1050/−1), angiotensin-converting enzyme (ACE) (ACE −1677/+21) and ACE2 (ACE2 −1091/+83). Results Sry1, Sry2 and Sry3 differentially upregulated activity of the promoters of angiotensinogen, renin and ACE genes and downregulated ACE2 promoter activity. The largest effect was seen with Sry3, which increased activity of angiotensinogen promoter by 1.7-fold, renin promoter by 1.3-fold, ACE promoter by 2.6-fold and decreased activity of ACE2 promoter by 0.5-fold. The effect of Sry1 on promoter activity was significantly less than that of Sry3. Sry2 activated promoters at a significantly lower level than Sry1 did. The result of either an additive effect of Sry regulation of multiple genes in the renin–angiotensin system or alterations in expression of a single gene could favor increased levels of Ang II and decreased levels of Ang-(1-7). Conclusion These actions of Sry could result in increased blood pressure in males and contribute to sex differences in blood pressure.

10 April 2017 in Human Reproduction
Verified
Journal Article
Open access
PDF file
ICInes K. Cavallo
Ines K. Cavallo
CCCynthia Dela Cruz
Cynthia Dela Cruz
MOMarilene L. Oliveira
Marilene L. Oliveira
HPHelen Lima Del Puerto
Helen Lima Del Puerto
JDJúlia A. Dias
Júlia A. Dias
FRFernando M Reis
Fernando M Reis
Do angiotensin (Ang)-(1–7) levels in human ovarian follicular fluid (FF) correlate with the number and proportion of mature oocytes obtained for IVF? The present study shows for the first time that Ang-(1–7) levels in human FF correlate with the proportion of mature oocytes collected upon ovarian stimulation for IVF. Ang-(1–7) is an active peptide of the renin-angiotensin system that stimulates oocyte maturation in isolated rabbit and rat ovaries. However, its role in human ovulation remains unexplored. This was a prospective cohort study including 64 participants from a single IVF center. Sample size was calculated to achieve a statistical power of 80% in detecting 20% differences in the proportion of mature oocytes between groups. The participants were enrolled in the study during six consecutive months. Plasma samples were obtained from all subjects at Day 21 of the last menstrual cycle before starting pituitary blockade and controlled ovarian stimulation (COS). Plasma and FF samples were quickly mixed with a protease inhibitor cocktail and stored at −80°C. Ang-(1–7) was quantified in plasma and FF samples by a highly sensitive and specific radioimmunoassay, which was preceded by solid phase extraction, speed vacuum concentration and sample reconstitution in assay buffer. FF Ang-(1–7) levels were stratified into tertiles and the patients of each tertile were compared for COS/IVF outcomes using Kruskal–Wallis ANOVA. Multiple regression analysis was used to adjust correlations for potential confounders. The mRNA encoding for Mas, a receptor for Ang-(1–7), was investigated by real-time PCR in luteinized granulosa cells purified from the FF. There was a four-fold increase in plasma Ang-(1–7) after ovulation induction (median 160.9 vs 41.4 pg/ml, P < 0.0001). FF Ang-(1–7) levels were similar to (169.9 pg/ml) but did not correlate with plasma Ang-(1–7) levels (r = −0.05, P = 0.665). Patients at the highest FF Ang-(1–7) tertile had a higher proportion of mature oocytes compared to patients at the lower FF Ang-(1–7) tertile (median 100% vs 70%, P < 0.01). There was a linear correlation between FF Ang-(1–7) and the proportion of mature oocytes (r = 0.380, P < 0.01), which remained significant after adjustment for age and duration of infertility (r = 0.447, P < 0.001). The luteinized granulosa cells expressed Mas receptor mRNA, which was positively correlated to the number of mature oocytes in women with more than three mature oocytes retrieved (r = 0.42, P < 0.01). This is an observational study, therefore, no causal relationship can be established between Ang-(1–7) and human oocyte maturation. Mas protein expression was not quantified due to limited availability of granulosa cells. Since this peptide promotes oocyte maturation in other species, it deserves further investigation as a potential maturation factor to human oocytes. Research supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG). The authors have nothing to disclose.

1 January 2010 in Genetics and Molecular Research
Verified
Journal Article
Closed access
HPHelen Lima Del Puerto
Helen Lima Del Puerto
AMALMIR DE SOUSA MARTINS
ALMIR DE SOUSA MARTINS
LML. Moro
L. Moro
AMA. Milsted
A. Milsted
FAF. Alves
F. Alves
AVA.C. Vasconcelos
A.C. Vasconcelos
Canine distemper is an immunosuppressive disease caused by the canine distemper virus (CDV). Pathogenesis mainly involves the central nervous system and immunosuppression. Dogs naturally infected with CDV develop apoptotic cells in lymphoid tissues and the cerebellum, but this apoptotic mechanism is not well characterized. To better understand this process, we evaluated the expression of Bax, Bcl-2, and caspase-3, -8 and -9, by evaluating mRNA levels in the peripheral blood, lymph nodes and cerebellum of CDV-infected (CDV+) and uninfected (CDV-) dogs by real-time polymerase chain reaction (PCR). Blood samples from 12 CDV+ and 8 CDV- dogs, diagnosed by reverse transcription-PCR, were subjected to hematological analysis and apoptotic gene expression was evaluated using real-time-PCR. Tissues from the cerebellum and lymph nodes of four CDV+ and three CDV-dogs were also subjected to real time-PCR. No significant differences were found between CDV+ and CDV- dogs in the hemotological results or in the expression of caspase-3, -8, -9, Bax, and Bcl-2 in the peripheral blood. However, expression of Bax, caspase-3, -8 and -9 was significantly higher in the cerebellum of CDV+ compared to CDV- dogs. Expression of caspase-3 and -8 was significantly higher in the lymph nodes of CDV+ compared to CDV- dogs. We concluded that infection with CDV induces apoptosis in the cerebellum and lymph nodes in different ways. Lymph node apoptosis apparently occurs via caspase-3 activation, through the caspase-8 pathway, and cerebellum apoptosis apparently occurs via caspase-3 activation, through the caspase-8 and mitochondrial pathways.

27 March 2012 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
BHBarbara Hissa
Barbara Hissa
JDJacqueline G. Duarte
Jacqueline G. Duarte
LKLudmila F. Kelles
Ludmila F. Kelles
FSFabio P. Santos
Fabio P. Santos
HPHelen Lima Del Puerto
Helen Lima Del Puerto
LALuciana O. Andrade
Luciana O. Andrade
Trypomastigotes of Trypanosoma cruzi are able to invade several types of non-phagocytic cells through a lysosomal dependent mechanism. It has been shown that, during invasion, parasites trigger host cell lysosome exocytosis, which initially occurs at the parasite-host contact site. Acid sphingomyelinase released from lysosomes then induces endocytosis and parasite internalization. Lysosomes continue to fuse with the newly formed parasitophorous vacuole until the parasite is completely enclosed by lysosomal membrane, a process indispensable for a stable infection. Previous work has shown that host membrane cholesterol is also important for the T. cruzi invasion process in both professional (macrophages) and non-professional (epithelial) phagocytic cells. However, the mechanism by which cholesterol-enriched microdomains participate in this process has remained unclear. In the present work we show that cardiomyocytes treated with MβCD, a drug able to sequester cholesterol from cell membranes, leads to a 50% reduction in invasion by T. cruzi trypomastigotes, as well as a decrease in the number of recently internalized parasites co-localizing with lysosomal markers. Cholesterol depletion from host membranes was accompanied by a decrease in the labeling of host membrane lipid rafts, as well as excessive lysosome exocytic events during the earlier stages of treatment. Precocious lysosomal exocytosis in MβCD treated cells led to a change in lysosomal distribution, with a reduction in the number of these organelles at the cell periphery, and probably compromises the intracellular pool of lysosomes necessary for T. cruzi invasion. Based on these results, we propose that cholesterol depletion leads to unregulated exocytic events, reducing lysosome availability at the cell cortex and consequently compromise T. cruzi entry into host cells. The results also suggest that two different pools of lysosomes are available in the cell and that cholesterol depletion may modulate the fusion of pre-docked lysosomes at the cell cortex. Trypanosoma cruzi, is the etiological agent of a neglected tropical malady known as Chagas' disease, which affects about 8 million people in Latin America. 30–40% of affected individuals develop a symptomatic chronic infection, with cardiomyopathy being the most prevalent condition. T. cruzi utilizes an interesting strategy for entering cells: T. cruzi enhances intracellular calcium levels, which in turn trigger the exocytosis of lysosomal contents. Lysosomes then donate their membrane for the formation of the parasitophorous vacuole. Membrane rafts, cholesterol-enriched microdomains in the host cell plasma membrane, have also been implicated in T. cruzi invasion process. Since both plasma membrane and lysosomes collaborate in parasite invasion, we decided to study the importance of these membrane domains for lysosomal recruitment and fusion during T. cruzi invasion into host cells. Our results show that drug dependent depletion of plasma membrane cholesterol changes raft organization and induces excessive lysosome exocytosis in the earlier stages of treatment, leading to a depletion of lysosomes near the cell cortex, which in turn compromises T. cruzi invasion. Based on these results, we propose that cholesterol depletion leads to unregulated exocytic events of pre-docked lysosomes, reducing lysosome availability at the cell cortex and consequently compromising T. cruzi infection.

1 October 2012 in Veterinary Parasitology
Verified
Journal Article
Closed access
BVBárbara Laurice Araújo Verçosa
Bárbara Laurice Araújo Verçosa
MMMaria Norma Melo
Maria Norma Melo
HPHelen Lima Del Puerto
Helen Lima Del Puerto
IMIvete Lopes Mendonça
Ivete Lopes Mendonça
AVAnilton César Vasconcelos
Anilton César Vasconcelos